Quick Takeaways: Why It Matters? Piclidenoson’s Phase 2 enrollment milestone, fully funded by Vetbiolix, moves this A3 adenosine receptor agonist closer to potential registration as a chronic oral osteoarthritis option in dogs, with LOAD, VAS, and ...
Quick Takeaways: Why It Matters? SmartTag turns vaccine tags into a digital tether between pets and their home clinics, giving owners instant, scan-based proof of vaccination while offloading verification requests and gap-identification to VetVerifi’s networ...
Quick Takeaways: Why It Matters? Darelle’s partnership with Pet Investment uses OneKindly’s fundraising tech to open a new, pet‑focused vertical, creating digital tools that help welfare groups and clinics unlock more financial support for veterinary care. Early ...
Quick Takeaways: Why It Matters? Dyne Soft Chews extends PetAg’s brand from specialty nutrition into the fast‑growing daily supplement segment, using vet‑formulated, clinically studied ingredients to compete more directly with premium wellness chew players ...
Quick Takeaways: Why It Matters? By extending Bravecto Quantum’s label to cover Asian longhorned and Gulf Coast ticks for a full 12 months, Merck further differentiates the product as the longest‑lasting, broadest‑spectrum injectable parasiticide available exclusively...
Quick Takeaways: Why It Matters? Fi Intelligence turns Fi’s collar base into a differentiated data platform, using longitudinal, dog‑specific signals plus population benchmarks to move beyond step counts into early-warning health insights that other ge...
Quick Takeaways: Why It Matters? ALA-1000’s data support a true once-monthly, long-acting analgesic option, which could meaningfully shift osteoarthritis pain management away from daily oral medications in suitable dogs. If approved, the combination of dura...
Quick Takeaways: Why It Matters? The renewed partnership reinforces Royal Canin’s positioning as a science-first leader in obesity and weight-management diets, backed by real-world clinical outcomes from an academic center. By combining low-cost clinical care with precisio...
Quick Takeaways: Why It Matters? The strong equine proof‑of‑concept data, clean safety profile, and upcoming human knee OA feasibility study collectively de‑risk Hydrocelin’s translational path, increasing its attractiveness as a first‑in‑class, potentially disease‑mo...
Quick Takeaways: Why It Matters? Relocating the HQ to Boston embeds Dechra in a top-tier life sciences cluster, improving access to R&D talent, BD opportunities, and capital for innovation-driven growth. The shift also signals a stronger strategic emphasis on...
